• Contacto
En
  • Es
logo-2k25logo-2k25logo-2k25logo-2k25
  • About us
    • What is NEUROFAN?
    • Who are we?
    • Where are we?
    • Contact
  • Publications
  • Projects
    • Aging and dementias
    • Pharmacogenomics and pharmacoepigenomics
    • Research in Addictive Disorders
    • Neuroinflammation and neurodegeneration
  • Resources
    • Links of interest
    • Multimedia
  • News
    • NEUROFAN in the media
    • Communications
✕
Lots of cannabis, synthetic drugs and pills, is there anything real about ‘Euphoria’?
Adefarma and Bidafarma reward a work on opioids in breakthrough cancer pain
Chemical submission drugs: effects, uses and prevention
CEU researchers find possible improvements in the treatment of Parkinson’s
The future of the pharmaceutical profession and the importance of pharmaceutical care and pharmacotherapeutic follow-up
The Spanish pharmaceutical system, the future of the pharmaceutical profession and the importance of pharmaceutical care and pharmacotherapeutic follow-up
Russian soldiers who occupied Chernobyl could suffer from burns, hair loss and cancer
The discovery of a protein that can be potentially useful as a therapeutic target for the treatment of Alzheimer’s
Advances in the investigation of behavioral addictions. Advances in Behavioral Addiction Research – Magisnet
123

Grupo Neurofarmacología de las adicciones y los trastornos degenerativos NEUROFAN

2025 Fundación Universitaria San Pablo CEU. Todos los derechos reservados

Contacto Aviso legal Política de privacidad Política de cookies
    • English
    • Español
    • Contacto

      En
      • Es
      cerrar-popup

      • English
      • Español (Spanish)